American Century Companies’s Structure Therapeutics GPCR Stock Holding History

American Century Companies's GPCR Position: Q2 2026 in Review

American Century Companies increased its Structure Therapeutics (GPCR) stake by 17% in Q2 2026, buying an estimated $10.8M and bringing the position to 1,682,179 shares worth $90.3M. The position accounts for 0.04% of the portfolio, ranked #557.

American Century Companies first reported a position in GPCR in Q1 2024 and has held it in 10 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

• American Century Companies held 1,682,179 shares of Structure Therapeutics worth $90.3M as of Q2 2026.
• American Century Companies bought 244,148 Structure Therapeutics shares in Q2 2026, an estimated $10.8M.
• Structure Therapeutics made up 0.04% of American Century Companies's portfolio in Q2 2026, its #557 holding.
• American Century Companies first reported a position in Structure Therapeutics in Q1 2024 and has held it in 10 quarters since.
• 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.